Ryan Daws To CFO At Concert Pharmaceuticals
January 23, 2014
Concert Pharmaceuticals, Inc. today announced the appointment of Ryan Daws as Chief Financial Officer. Prior to joining Concert, Daws was a Director in the Healthcare Investment Banking Group from 2010 to 2013 at Stifel, Nicolaus & Company, Inc., a financial services company. From 1999 to 2010, he served in positions of increasing responsibility within the Healthcare Investment Banking Group of Cowen and Company, LLC, a financial services firm.
Read full article at:
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.